Why Macquarie thinks this ASX All Ords stock is set to rocket 83%

Here's what the broker had to say.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is unlikely to rocket 83% in a year, but this promising ASX All Ords stock just might.

That's according to the team over at Macquarie Group Ltd (ASX: MQG).

The potentially resurgent company in question is Aussie retail jewellery chain Michael Hill International Ltd (ASX: MHJ).

Michael Hill shares closed on Friday trading for 41 cents apiece.

That sees this ASX All Ords stock down 26% since this time last year. And stockholders won't have gotten any relief from dividends this past year. Michael Hill's last interim dividend payout was delivered on 22 March 2024.

But according to Macquarie, the year ahead should be much more profitable for stockholders, not just in terms of share price gains but also with a potential return of the Michael Hill dividend.

Here's what the broker had to say.

A woman stares directly ahead wearing diamond earrings, diamond necklace and diamond bracelet.

Image source: Getty Images

Time to buy this beaten-down ASX All Ords stock?

Michael Hill reported its FY 2025 trading update results on 31 July.

Commenting on the ASX All Ords stock's full-year performance, Macquarie said, "In a difficult trading environment, the delivery of flat group revenue in FY25 was a solid result, with only NZ in negative territory."

The broker added:

Initiatives aimed at protecting near term GP [gross profit] margins, and providing a platform for reflation towards a target level of ~64% gained traction over the year, and in 2H25 MHJ addressed some of the operating cost pressure that underpinned lower comparable EBIT [earnings before interest and tax] in 1H25 vs pcp, including the closure on EBIT loss making stores, supply chain improvements and enhanced product ranging, pricing and promotional programs.

Looking ahead, Macquarie expects Michael Hill could double its earnings inside the next two years. And that should become evident in the year ahead.

Macquarie said:

We see a clear path for MHJ to deliver near-term comparable EBIT of ~ $30m (double the FY24/FY25 level), probably achievable in FY27, with a step change toward that target expected in FY26.

As for the return of that welcome passive income, the ASX All Ords stock is unlikely to pay a final dividend this year. But Macquarie expects the Michael Hill dividend to make a comeback in FY 2027, or sooner.

"We continue to forecast no dividend for FY25," the broker said. "While our forecast have dividends resuming on FY27, we would expect the board to review the possible resumption of dividends in FY26, depending on trading outcomes."

Connecting the dots, Macquarie concluded:

While MHJ faces near-term operating headwinds (albeit reducing), the magnitude of the prevailing discount to assessed fair value, the expected recovery in GP margins and identified multi-channel growth initiatives combine to support our outperform rating.

Macquarie has a 12-month target price of 75 cents per share for the ASX All Ords stock.

That's 83% above Friday's closing price of 41 cents per share.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »